{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:50:03Z","timestamp":1794037803805,"version":"4.8.0"},"reference-count":26,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bras Pneumol."],"abstract":"<jats:p>Objective: To describe the impact of severe asthma in a real-life cohort in Brazil, reporting on baseline clinical characteristics, access to treatment, and clinical remission under treatment with biologics. Methods: Severe asthma patients &gt; 6 years of age were recruited from 23 centers in Brazil. Data on clinical characteristics, lung function, biomarkers, prescribed therapies, and clinical remission under treatment were collected at the baseline visit. Results: A total of 417 patients were recruited. Of the 162 adult patients, 71% had a history of hospitalization, with 31% having experienced more than two severe exacerbations in the last 12 months and 6% having experienced cardiopulmonary arrest. Allergic and eosinophilic phenotypes were the most common phenotypes in all age groups, with the T2-low phenotype being observed in 10% of the pediatric patients and in 20% of the adult patients. Only 10% of the adult patients and 1% of the pediatric patients were receiving maintenance oral corticosteroids, whereas 41% of the adult patients were under treatment with biologics, with clinical remission being achieved in 20%. Conclusions: Severe asthma in Brazil still results in a high disease burden, with less than half of the patients receiving treatment with biologics and clinical remission being achieved in a subgroup of patients treated with biologics for more than 12 months. Achieving disease control remains a major clinical and health care challenge, requiring further actions from specialists and health care providers, as well as additional studies.<\/jats:p>","DOI":"10.36416\/1806-3756\/e20240427","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T21:50:38Z","timestamp":1751061038000},"page":"e20240427","source":"Crossref","is-referenced-by-count":2,"title":["Baseline characteristics of patients from the Brazilian Severe Asthma Registry: the REBRAG study"],"prefix":"10.36416","author":[{"given":"Paulo","family":"Marcio Pitrez1","sequence":"first","affiliation":[{"name":"1. Hospital Santa Casa de Porto Alegre, Pavilh\u00e3o Pereira Filho, Porto Alegre (RS) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora","family":"Carla Chong-Silva2","sequence":"additional","affiliation":[{"name":"2. Complexo Hospital de Cl\u00ednicas da Universidade Federal do Paran\u00e1, Curitiba (PR) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faradiba","family":"Sarquis Serpa3","sequence":"additional","affiliation":[{"name":"3. Hospital Santa Casa de Miseric\u00f3rdia de Vit\u00f3ria, Centro de Refer\u00eancia em Asma Grave, Vit\u00f3ria (ES) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelmir","family":"Souza-Machado4","sequence":"additional","affiliation":[{"name":"4. Instituto de Ci\u00eancias da Sa\u00fade, Universidade Federal da Bahia, Salvador (BA) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adalberto","family":"Sperb Rubin1","sequence":"additional","affiliation":[{"name":"1. Hospital Santa Casa de Porto Alegre, Pavilh\u00e3o Pereira Filho, Porto Alegre (RS) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"da Rocha Oliveira Cardoso5","sequence":"additional","affiliation":[{"name":"5. Hospital das Cl\u00ednicas da Universidade Federal de Goi\u00e1s, Goi\u00e2nia (GO) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adyl\u00e9ia","family":"Aparecida Dalbo Contrera Toro6","sequence":"additional","affiliation":[{"name":"6. Centro de Investiga\u00e7\u00e3o em Pediatria, Universidade Estadual de Campinas, Campinas (SP) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Maria de Lima Belizario Facury Lasmar7","sequence":"additional","affiliation":[{"name":"7. Centro Multidisciplinar para Pacientes com Asma de Dif\u00edcil controle - CEMAD - Hospital das Cl\u00ednicas - HCUFMG\/Ebserh - Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte (MG) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Cavalet Blanco8","sequence":"additional","affiliation":[{"name":"8. Pontif\u00edcia Universidade Cat\u00f3lica do Rio Grande do Sul, Porto Alegre (RS) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"de Freitas Velloso Monte9","sequence":"additional","affiliation":[{"name":"9. Hospital da Crian\u00e7a de Bras\u00edlia Jos\u00e9 Alencar, Bras\u00edlia (DF) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Andrade Lima10","sequence":"additional","affiliation":[{"name":"10. Hospital Dia do Pulm\u00e3o, Blumenau (SC) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Gustavo Barian Romaldini11","sequence":"additional","affiliation":[{"name":"11. Hospital Santa Casa de Miseric\u00f3rdia de S\u00e3o Paulo, S\u00e3o Paulo (SP) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Costa de Freitas Silva12","sequence":"additional","affiliation":[{"name":"12. Servi\u00e7o de Alergia e Imunologia, Universidade Estadual do Rio de Janeiro, Rio de Janeiro (RJ) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Ticiana Dias Ferreira13","sequence":"additional","affiliation":[{"name":"13. Hospital das Cl\u00ednidas da Universidade Federal de Pernambuco, Recife (PE) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Augusto Souza da Cruz Filho14","sequence":"additional","affiliation":[{"name":"14. Programa de P\u00f3s-Gradua\u00e7\u00e3o em Medicina e Sa\u00fade e Funda\u00e7\u00e3o ProAR, Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador (BA) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Margaret Menezes Pizzichini15","sequence":"additional","affiliation":[{"name":"15. Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias M\u00e9dicas, Universidade Federal de Santa Catarina, Florian\u00f3polis (SC) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"the REBRAG","family":"group1","sequence":"additional","affiliation":[{"name":"1. Hospital Santa Casa de Porto Alegre, Pavilh\u00e3o Pereira Filho, Porto Alegre (RS) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22288","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"ref0","unstructured":"1.           Global Initiative for Asthma (GINA) [homepage on the Internet]. Bethesda: GINA; c2022 [cited 2024 Dec 23]. 2024 GINA Main Report. Available from: https:\/\/ginasthma.org\/2024-report\/"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2.           Hekking PW, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135(4):896-902. https:\/\/doi.org\/10.1016\/j.jaci.2014.08.042","DOI":"10.1016\/j.jaci.2014.08.042"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3.           Busse WW, Fang J, Marvel J, Tian H, Altman P, Cao H. Uncontrolled asthma across GINA treatment steps 2 - 5 in a large US patient cohort. J Asthma. 2022;59(5):1051-1062. https:\/\/doi.org\/10.1080\/02770903.2021.1897834","DOI":"10.1080\/02770903.2021.1897834"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4.           Miller MK, Lee JH, Miller DP, Wenzel SE; TENOR Study Group. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med. 2007;101(3):481-9. https:\/\/doi.org\/10.1016\/j.rmed.2006.07.005","DOI":"10.1016\/j.rmed.2006.07.005"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5.           de Carvalho-Pinto RM, Cukier A, Angelini L, Antonangelo L, Mauad T, Dolhnikoff M, et al. Clinical characteristics and possible phenotypes of an adult severe asthma population. Respir Med. 2012;106(1):47-56. https:\/\/doi.org\/10.1016\/j.rmed.2011.08.013","DOI":"10.1016\/j.rmed.2011.08.013"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6.           Tai A, Tran H, Roberts M, Clarke N, Wilson J, Robertson CF. The association between childhood asthma and adult chronic obstructive pulmonary disease. Thorax. 2014;69(9):805-810. https:\/\/doi.org\/10.1136\/thoraxjnl-2013-204815","DOI":"10.1136\/thoraxjnl-2013-204815"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.           Nascimento OA, Can\u00e7ado JED, Gazzotti MR, Dos Santos FM, Saturnino LTM, da Silva DO, et al. The economic impact of asthma on private healthcare system in Brazil: Economic impact of asthma in Brazil. Medicine (Baltimore). 2023;102(12):e33077. https:\/\/doi.org\/10.1097\/MD.0000000000033077","DOI":"10.1097\/md.0000000000033077"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8.           Mortimer K, Reddel HK, Pitrez PM, Bateman ED. Asthma management in low and middle income countries: case for change. Eur Respir J. 2022;60(3):2103179. https:\/\/doi.org\/10.1183\/13993003.03179-2021","DOI":"10.1183\/13993003.03179-2021"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"9.           Cushen B, Koh MS, Tran TN, Martin N, Murray R, Uthaman T, et al. Adult Severe Asthma Registries: A Global and Growing Inventory. Pragmat Obs Res. 2023;14:127-147. https:\/\/doi.org\/10.2147\/POR.S399879","DOI":"10.2147\/POR.S399879"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10.        Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement Am J Respir Crit Care Med. 2019;200(8):e70-e88. https:\/\/doi.org\/10.1164\/rccm.201908-1590ST","DOI":"10.1164\/rccm.201908-1590st"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11.        Menzies-Gow A, Bafadhel M, Busse WW, Casale TB, Kocks JWH, Pavord ID, et al. An expert consensus framework for asthma remission as a treatment goal. J Allergy Clin Immunol. 2020;145(3):757-765. https:\/\/doi.org\/10.1016\/j.jaci.2019.12.006","DOI":"10.1016\/j.jaci.2019.12.006"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12.        Wang E, Wechsler ME, Tran TN, Heaney LG, Jones RC, Menzies-Gow AN, et al. Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry. Chest. 2020;157(4):790-804. https:\/\/doi.org\/10.1016\/j.chest.2019.10.053","DOI":"10.1016\/j.chest.2021.09.030"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13.        Funda\u00e7\u00e3o Oswaldo Cruz (FIOCRUZ) [homepage da internet]. Rio de Janeiro: FIOCRUZ; c2020 [cited 2024 Dec 23]. Pesquisa Nacional de Sa\u00fade - Painel de Indicadores. Available from: https:\/\/www.pns.icict.fiocruz.br\/painel-de-indicadores-mobile-desktop\/","DOI":"10.22239\/2317-269x.01561"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"14.        Scelo G, Torres-Duque CA, Maspero J, Tran TN, Murray R, Martin N, et al. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry. Ann Allergy Asthma Immunol. 2024;132(1):42-53. https:\/\/doi.org\/10.1016\/j.anai.2023.08.021","DOI":"10.1016\/j.anai.2023.08.021"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"15.        Can\u00e7ado JED, Penha M, Gupta S, Li VW, Julian GS, Moreira ES. Respira project: Humanistic and economic burden of asthma in Brazil. J Asthma. 2019;56(3):244-251. https:\/\/doi.org\/10.1080\/02770903.2018.1445267","DOI":"10.1080\/02770903.2018.1445267"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16.        Brum M, Henz J, Boeira M, Soares S, Friedrich F, Pitrez PM. Recent increase in asthma mortality in Brazil: a warning sign for the public health system. J Bras Pneumol. 2024;50(5):e20240138. https:\/\/doi.org\/10.36416\/1806-3756\/e20240138","DOI":"10.36416\/1806-3756\/e20240138"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17.        Tai A, Tran H, Roberts M, Clarke N, Gibson AM, Vidmar S, et al. Outcomes of childhood asthma to the age of 50 years. J Allergy Clin Immunol. 2014;133(6):1572-1578.e3. https:\/\/doi.org\/10.1016\/j.jaci.2013.12.1033","DOI":"10.1016\/j.jaci.2013.12.1033"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"18.        McGeachie MJ, Yates KP, Zhou X, Guo F, Sternberg AL, Van Natta ML, et al. Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med. 2016;374(19):1842-1852. https:\/\/doi.org\/10.1056\/NEJMoa1513737","DOI":"10.1056\/NEJMoa1513737"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"19.        Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18(5):716-725. https:\/\/doi.org\/10.1038\/nm.2678","DOI":"10.1038\/nm.2678"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20.        Athanazio R, Stelmach R, Antila M, Souza-Machado A, Arruda LK, Cerci Neto A, et al. Prevalence of the eosinophilic phenotype among severe asthma patients in Brazil: the BRAEOS study. J Bras Pneumol. 2022;48(3):e20210367. https:\/\/doi.org\/10.36416\/1806-3756\/e20210367","DOI":"10.36416\/1806-3756\/e20210367"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"21.        Denton E, Hew M, Peters MJ, Upham JW, Bulathsinhala L, Tran TN, et al. Real-world biologics response and super-response in the International Severe Asthma Registry cohort. Allergy. 2024;79(10):2700-2716. https:\/\/doi.org\/10.1111\/all.16178","DOI":"10.1111\/all.16178"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22.        US Food & Drug Administration (FDA) [homepage on the Internet]. Silver Spring, MD: FDA; c2023 [updated 2020 Mar 13; cited 2024 Sep 23]. FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis. Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-requires-boxed-warning-about-serious-mental-health-side-effects-asthma-and-allergy-drug","DOI":"10.2165\/00128415-200912610-00007"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23.        Hamada Y, Gibson PG, Harvey ES, Stevens S, Lewthwaite H, Fricker M, et al. Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma. J Allergy Clin Immunol Pract. 2025;13(2):333-342.e9. https:\/\/doi.org\/10.1016\/j.jaip.2024.10.041","DOI":"10.1016\/j.jaip.2024.10.041"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24.        Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012;380(9842):651-9. https:\/\/doi.org\/10.1016\/S0140-6736(12)60988-X","DOI":"10.1016\/s0140-6736(12)60988-x"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25.        Wechsler ME, Brusselle G, Virchow JC, Bourdin A, Kostikas K, Llanos JP, et al. Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies. Eur Respir J. 2024;64(6):2400316. https:\/\/doi.org\/10.1183\/13993003.00316-2024","DOI":"10.1183\/13993003.00316-2024"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26.        Chipps BE, Lugogo N, Carr W, Zhou W, Patel A, Carstens DD, et al. On-treatment clinical remission of severe asthma with real-world longer-term biologic use. J Allergy Clin Immunol Glob. 2025;4(1):100365. https:\/\/doi.org\/10.1016\/j.jacig.2024.100365","DOI":"10.1016\/j.jacig.2024.100365"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T21:50:41Z","timestamp":1751061041000},"score":1,"resource":{"primary":{"URL":"https:\/\/jornaldepneumologia.com.br\/details\/4114\/en-US"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":26,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20240427","relation":{},"ISSN":["1806-3756"],"issn-type":[{"value":"1806-3756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]}}}